In a groundbreaking shift, CVS has announced a significant change to its drug pricing formula, aimed at enhancing transparency and simplifying costs for consumers. This strategic adjustment is ...
CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.